Seronegative Myasthenia Gravis - Efgartigimod IV
Abroad (travel likely)RecruitingPHASE3
Conditions
Efgartigimod · Generalized Myasthenia Gravis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University Health Network, Division of Neurology, Toronto General Hospital, Toronto, Ontario, Canada
Contact: Study coordinator (Vera Bril, MD)
Study leads
Vera Bril, MD
Principal Investigator
Toronto General Hospital